Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 7/20 | 0.62 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.51 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.49 |
| ▸ | IDH2 | P48735 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5213164 | 0.87 | KDM4E (0.59) | FABP4FABP5MEN1KMT2AIRAK4 | |
| SCHEMBL17796963 | 0.86 | FABP4 (0.62) | FABP4FABP5MEN1KMT2ASERPINE1 | |
| SCHEMBL21030832 | 0.85 | KCNMA1 (0.68) | FABP4FABP5MEN1KMT2AIRAK4 | |
| SCHEMBL3906980 | 0.81 | HDAC7 (0.53) | MEN1KMT2AKDM4ENPSR1KCNMA1 | |
| SCHEMBL5099460 | 0.81 | TDP1 (0.57) | MEN1KMT2AKDM4ENPSR1ALDH1A1 | |
| SCHEMBL27923018 | 0.81 | ALOX5 (0.55) | FABP4FABP5MEN1KMT2AIDH2 | |
| SCHEMBL11160989 | 0.80 | FABP4 (0.52) | FABP4FABP5MEN1KMT2AIRAK4 | |
| SCHEMBL3913042 | 0.80 | CHRM1 (0.56) | MEN1KMT2AKDM4ENPSR1ALDH1A1 | |
| SCHEMBL3846891 | 0.80 | IDH2 (0.51) | FABP4IDH2GRIK1 | |
| Trifluoroacetic Acid SCHEMBL5113233 | 0.79 | FABP4 (0.46) | FABP4FABP5MEN1KMT2AIDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080249127-A1 | Muscarinic Acetylcholine Receptor Antagonists | LAINE DRAMANE I | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249127-A1 | Muscarinic Acetylcholine Receptor Antagonists | CHRM3, CHRNG, CHRM2 | FABP4 4255/4885FABP5 1382/4885MEN1 4053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.